US researchers are testing YCT-529, a hormone-free male birth control pill that could redefine family planning.

It's also self-injectable and less painful than traditional implant options, according to research in rodents.

YCT-529, a hormone-free male birth control pill, has shown high effectiveness in animals and is now in human trials, marking ...

The University of Minnesota's College of Pharmacy has paved the way for the first non-hormonal male birth control pill to enter clinical trials.

Allied Market Research published a report, titled, "Hormonal Contraceptive Market by Product (Oral Contraceptive Pills, ...

and availability of advanced contraceptive options. WILMINGTON, Del., March 25, 2025 /PRNewswire/ -- Allied Market Research published a report, titled, "Hormonal Contraceptive Market by Product ...

Mass General Brigham and MIT investigators have developed a long-acting contraceptive implant that can be delivered through ...

Investigators have developed a long-acting contraceptive implant that can be delivered through tiny needles to minimize patient discomfort and increase the likelihood of medication use. Their findings ...

Researchers at the Massachusetts Institute of Technology (MIT) claimed to have developed a new self-administered injection ...

BREAKING: Following Dobbs v. Jackson, the United States saw a 10 percent increase in interest for new male contraceptives, ...

Novel drug delivery approach that utilizes long-acting injectable microcrystals may enable new options for long-term delivery of contraceptives.

Depo-Provera, a commonly used injectable contraceptive, has been linked to an increased risk of meningiomas, which are a type ...